[General undifferentiated estrogen (progestagen) substitution in the prevention of osteoporosis: contra].
作者信息
Ziegler R
出版信息
Med Klin (Munich). 1987 Mar 20;82(6):241-4.
PMID:3587169
Abstract
摘要
相似文献
1
[General undifferentiated estrogen (progestagen) substitution in the prevention of osteoporosis: contra].[普通未分化雌激素（孕激素）替代疗法预防骨质疏松症：反对意见]
Med Klin (Munich). 1987 Mar 20;82(6):241-4.
2
Prevention of postmenopausal osteoporosis by estrogen/gestagen substitution therapy.雌激素/孕激素替代疗法预防绝经后骨质疏松症。
Med Klin (Munich). 1987 Mar 20;82(6):238-41.
3
Physicians changing postmenopausal sex hormone prescribing regimens.
Prog Clin Biol Res. 1986;216:325-35.
4
[Thoughts on long-term estrogen substitution--should gynecologists change their mind?].[关于长期雌激素替代疗法的思考——妇科医生是否应该改变想法？]
Geburtshilfe Frauenheilkd. 1985 May;45(5):326-32. doi: 10.1055/s-2008-1036469.
5
Hormone replacement therapy and cancer.
Br J Hosp Med. 1989 Feb;41(2):142, 144-6, 148-9.
6
[What is appropriate in postmenopausal osteoporosis?].绝经后骨质疏松症的适宜治疗方法是什么？
Z Gesamte Inn Med. 1988 Aug 1;43(15):416-8.
7
[Oral hormone therapy in the pre- and postmenopausal period].
Gynakologe. 1986 Dec;19(4):235-40.
8
[Value of progestagens in estrogen replacement therapy].
Ginekol Pol. 1979;Suppl:286-7.
9
[Estrogen metabolism and hormone substitution in the climacteric].
Zentralbl Gynakol. 1985;107(16):977-88.
10
Preventing postmenopausal osteoporosis with estrogen replacement therapy.雌激素替代疗法预防绝经后骨质疏松症。
Int J Fertil. 1986;31(3 Suppl [ESTROGEN]):15-20.
Zotero 插件